Congenital organic hyperinsulinism associated with a variant in the ABCC8 gene. Description of a family case

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Hypoglycemia is the most common metabolic disorder occurring in early childhood, which can be the first, and sometimes the only symptom of a whole range of diseases. Etiology determines the characteristic clinical features of the course of hypoglycemic syndrome. Diagnosis is complicated by the fact that the clinical manifestations of hypoglycemia are variable and little specific. The main cause of persistent hypoglycemia in children of the first years of life is congenital hyperinsulinism.

Congenital hyperinsulinism is a hereditary disease characterized by inadequate hypersecretion of insulin by beta cells of the pancreas. Manifesting as a rule in the neonatal period, congenital hyperinsulinism is a great threat, both in terms of survival of patients with late diagnosis, and in terms of the risks of severe neurological complications with inadequate therapy of emerging hypoglycemia.

The article describes a family case of congenital organic hyperinsulinism associated with a rare heterozygous mutation in the ABCC8 gene, the early diagnosis of which allowed avoiding severe complications of the disease and timely prescribing adequate treatment. The clinical variability of the course of the disease in related patients was shown, which required a personalized approach to diagnosis and treatment.

Thus, early detection of hypoglycemia, clarification of its etiology, including with the help of molecular genetic analysis, timely drug therapy and monitoring of the state of carbohydrate metabolism, are important aspects in the treatment and supervision of patients with congenital hyperinsulinism and the prevention of severe neurological complications in them.

Full Text

Restricted Access

About the authors

Dmitry O. Ivanov

Saint Petersburg State Pediatric Medical University

Author for correspondence.
Email: doivanov@yandex.ru
SPIN-code: 4437-9626

MD, PhD, Dr. Sci. (Med.), Professor, Chief Freelance Neonatologist of the Ministry of Health of Russia, rector, Head of the Department of Neonatology with Courses of Neurology and Obstetrics and Gynecology

Russian Federation, Saint Petersburg

Lilaya V. Ditkovskaya

Saint Petersburg State Pediatric Medical University

Email: Liliya-ditkovskaya@yandex.ru
SPIN-code: 5771-0580

MD, PhD, Associate Professor of the Children’s diseases them. Professor I.M. Vorontsov PhD and DPO

Russian Federation, Saint Petersburg

Mariia E. Turkunova

Children’s City Polyclinic No. 44

Email: 89650505452@mail.ru
SPIN-code: 7320-1136

MD, PhD, Children Endocrinologist

Russian Federation, Saint Petersburg

Evgeny N. Suspitsin

Saint Petersburg State Pediatric Medical University

Email: evgeny.suspitsin@gmail.com

MD, PhD, Associate Professor of the Department of Medical Genetics

Russian Federation, Saint Petersburg

References

  1. Avanesyan RI, Avdeeva TG, Alekseeva EI, et al. Pediatriya. Vol. 1. Moscow: GEOTAR-Media, 2009. (In Russ.)
  2. Ivanov DO, Novikova VP, Pokhlebkina AA. Congenital disorders of glycosylation. Pediatrician (St. Petersburg). 2018;9(3):5–15. (In Russ.) doi: 10.17816/PED935-15
  3. Melashenko TV, Guzeva VV, Malekov DA. The clinical case of symptomatic epilepsy in newborn with neonatal hypoglycemic encephalopathy. Pediatrician (St. Petersburg). 2016;7(4):147–152. (In Russ.) doi: 10.17816/PED74147-152
  4. Melikyan MA, Kareva MA. Vrozhdennyi giperinsulinizm. Posobie dlya vrachei. Moscow, 2017. 24 p. (In Russ.)
  5. Melikyan MA. Vrozhdennyi giperinsulinizm: molekulyarnaya osnova, klinicheskie osobennosti i personalizirovannoe lechenie [dissertation]. Moscow, 2019. 311 p. (In Russ.)
  6. Nikitina IL, Sarakaeva LR, Bairov VG, et al. Neurodevelopmental outcomes and neurophysiological parameters in children with congenital hyperinsulinism. Medical Council. 2022;(12):86–94. (In Russ.) doi: 10.21518/2079-701X-2022-16-12-86-94
  7. Aguilar-Bryan L, Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev. 1999;20(2):101–135. doi: 10.1210/er.20.2.101
  8. Arnoux J-B, Verkarre V, Saint-Martin C, et al. Congenital hyperinsulinism: Current trends in diagnosis and therapy. Orphanet J Rare Dis. 2011;6:63. doi: 10.1186/1750-1172-6-63
  9. Bhushan AV, Aziz Q, Nessa A, et al. Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy. Int J Pediatr Endocr. 2014;1:24. doi: 10.1186/1687-9856-2014-24
  10. Banerjee I, Raskin J, Arnoux J-B, et al. Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families. Orphanet J Rare Dis. 2022;17:61. doi: 10.1186/s13023-022-02214-y
  11. Verkarre V, Fournet JC, de Lonley P, et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest. 1998;102(7):1286–1191. doi: 10.1172/JCI4495
  12. Demirbilek H, Hussain K. Congenital hyperinsulinism: diagnosis and treatment update. J Clin Res Pediatr Endocr. 2017;9(S2):69–87. doi: 10.4274/jcrpe.2017.S007
  13. Giri D, Hawton K, Senniappan S. Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management. J Pediatr Endocr Metab. 2021;35(3):279–296. doi: 10.1515/jpem-2021-0369
  14. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. ADC Fetal and Neonatal Ed. 2000;82(2):79–86. doi: 10.1136/fn.82.2.F79
  15. Hewat TI, Johnson MB, Flanagan SE. Congenital hyperinsulinism: current laboratory-based approaches to the genetic diagnosis of a heterogeneous disease. Front Endocr. 2022;13:873254. doi: 10.3389/fendo.2022.873254
  16. Huopio H, Reimann F, Ashfield R, et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Investig. 2000;106(7):897–906. doi: 10.1172/JCI9804
  17. Lord K, De León DD. Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management. J Pediatr Endocr. 2013:3. doi: 10.1186/1687-9856-2013-3
  18. Mitrofanova LB, Perminova AA, Ryzhkova DV, et al. Differential morphological diagnosis of various forms of congenital hyperinsulinism in children. Front Endocr. 2021;12:710947. doi: 10.3389/fendo.2021.710947
  19. Rahier J, Guiot Y, Sempoux C. Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism. Semin Pediatr Surg. 2011;20(1):3–12. doi: 10.1053/j.sempedsurg.2010.10.010
  20. Rahman SA, Nessa A, Hussain K. Molecular mechanisms of congenital hyperinsulinism. J Mol Endocr. 2015;54(2):119–129. doi: 10.1530/JME-15-0016
  21. Saint-Martin C, Arnoux J-B, de Lonelay P, Bellanne-Chantelot C. KATP channel mutations in congenital hyperinsulinism. Semin Pediatr Surg. 2011;20(1):18–22. doi: 10.1053/j.sempedsurg.2010.10.012
  22. Sempoux C, Capito C, Bellanne-Chantelot C, et al. Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. J Clin Endocrinol Metab. 2011;96(12):3785–3793. doi: 10.1210/jc.2010-3032
  23. Snider KE, Becker S, Boyajian L, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab. 2013;98(2):355–363. doi: 10.1210/jc.2012-2169
  24. Zhang Y, Pi Y, Yan X, et al. Clinical features and genetic analysis of seven patients with congenital hyperinsulinism. Chin J Med Genet. 2018;35(4):502–506. doi: 10.3760/cma.j.issn.1003-9406.2018.04.009

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. PET CT results with 18F*-DOPA

Download (121KB)
3. Fig. 2. Daily sensory monitoring of glycemia in a patient with congenital hyperinsulinism

Download (255KB)
4. Fig. 3. The genealogy of the patient with congenital hyperinsulinism

Download (46KB)
5. Fig. 4. Daily sensory monitoring of glycemia in the mother of a patient with congenital hyperinsulinism

Download (249KB)
6. Fig. 5. Daily sensory monitoring of glycemia in the brother of a patient with congenital hyperinsulinism

Download (240KB)

Copyright (c) 2023 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies